UTHR
NASDAQ · Biotechnology
United Therapeutics Corp
$586.94
+4.48 (+0.77%)
Analyst Consensus
Strong Buy
22
Analysts
High
Coverage
Price Target
Analyst Price Target
-84.9% upside
Low Target
$65.70
Average Target
$88.53
High Target
$121.74
Current Price
$586.94
Current
$586.94
$586.94
Target
$88.53
$88.53
$65.70
$88.53 avg
$121.74
Scenario Analysis
Bear Case
$65.70
-88.8%
Low target
Base Case
$88.53
-84.9%
Avg target
Bull Case
$121.74
+-79.3%
High target
Risk/Reward
0.9x
Unfavorable
Price in Context
52-Week High
$614.23
-4.4% from high
52-Week Low
$432.53
+35.7% from low
50-Day SMA
$535.33
+9.6% vs SMA
200-Day SMA
$535.04
+9.7% vs SMA
RSI (14)
60.2
Neutral
Target vs 52W High
$88.53
-85.6% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -12.4% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.8% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +113.5% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -20.3% |
| MRNA | Hold | 31 | 32% | $149.45 | -42.1% |
| REGN | Buy | 36 | 72% | $76.80 | -91.6% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -54.5% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -40.3% |